Publications by authors named "Mathieu Robain"

Claim this Profile
A
Assessing the real-world effectiveness of 8 major metastatic breast cancer drugs using target trial emulation.
Alison Antoine, David Pérol, Mathieu Robain, Thomas Bachelot, Rémy Choquet

Eur J Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target trial emulation to assess real-world efficacy in the Epidemiological Strategy and Medical Economics metastatic breast cancer cohort.
Alison Antoine, David Pérol, Mathieu Robain, Suzette Delaloge, Christine Lasset

J Natl Cancer Inst· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database.
Coralie Courtinard, Sophie Gourgou, William Jacot, Matthieu Carton, Olivier Guérin, Mathieu Robain

BMC Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
William Jacot, Amélie Lusque, Cécile Vicier, Audrey Mailliez, Thibault de La Motte Rouge, Mathieu Robain

Br J Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclic fertilin-derived peptide stimulates in vitro human embryo development.
Anne-Lyse Denizot, Audrey L'Hostis, Amira Sallem, Sophie Favier, Rémi Pierre, Mathieu Robain

F S Sci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment strategies for unresectable locally advanced non-small cell lung cancer in the real-life ESME cohort.
Nicolas Girard, Maurice Perol, Gaëtane Simon, Clarisse Audigier Valette, Radj Gervais, Mathieu Robain

Lung Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research project.
Monia Ezzalfani, Raphaël Porcher, Alexia Savignoni, Suzette Delaloge, Thomas Filleron, Mathieu Robain

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program.
Luc Cabel, Matthieu Carton, Barbara Pistilli, Florence Dalenc, Laurence Vanlemnens, Mathieu Robain

Breast· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of body mass index on overall survival in patients with metastatic breast cancer.
Khalil Saleh, Matthieu Carton, Véronique Dieras, Pierre-Etienne Heudel, Etienne Brain, Mathieu Robain

Breast· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A response letter to comments on "Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016".
Elise Deluche, Alison Antoine, Thomas Bachelot, Mathieu Robain, David Perol

Eur J Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort.
Sophie Frank, Matthieu Carton, Coraline Dubot, Mario Campone, Barbara Pistilli, Mathieu Robain

Breast· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC Study.
Pierre Heudel, Suzette Delaloge, Damien Parent, Nicolas Madranges, Christelle Levy, Mathieu Robain

Anticancer Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis.
Elvire Pons-Tostivint, Youlia Kirova, Amélie Lusque, Mario Campone, Julien Geffrelot, Mathieu Robain

Radiother Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016.
Elise Deluche, Alison Antoine, Thomas Bachelot, Audrey Lardy-Cleaud, Veronique Dieras, Mathieu Robain

Eur J Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort.
David Pasquier, Amélie Darlix, Guillaume Louvel, Julien Fraisse, William Jacot, Mathieu Robain

Eur J Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program.
William Jacot, Pierre-Etienne Heudel, Julien Fraisse, Sophie Gourgou, Séverine Guiu, Mathieu Robain

Int J Cancer· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort.
Amélie Darlix, Guillaume Louvel, Julien Fraisse, William Jacot, Etienne Brain, Mathieu Robain

Br J Cancer· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the efficacy of successive endocrine therapies in hormone receptor-positive and HER2-negative metastatic breast cancer: a real-life multicentre national study.
Olivia Le Saux, Audrey Lardy-Cleaud, Sophie Frank, Marc Debled, Paul H Cottu, Mathieu Robain

Eur J Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis.
Elvire Pons-Tostivint, Youlia Kirova, Amélie Lusque, Mario Campone, Julien Geffrelot, Mathieu Robain

Ann Surg Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME).
David Pérol, Mathieu Robain, Patrick Arveux, Simone Mathoulin-Pélissier, Emmanuel Chamorey

BMJ Open· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physician-to-physician communication in breast cancer care coordination.
Delphine Héquet, Nicolas Pouget, Julien Seror, Cyrille Huchon, Mathieu Robain

Bull Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort.
Elisa Gobbini, Monia Ezzalfani, Véronique Dieras, Thomas Bachelot, Etienne Brain, Mathieu Robain

Eur J Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Driss Berdaï, Florence Thomas-Delecourt, Karine Szwarcensztein, , Anne d'Andon, Mathieu Robain

Therapie· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Requests for post-registration studies (PRS), patients follow-up in actual practice: Changes in the role of databases.
Driss Berdaï, Florence Thomas-Delecourt, Karine Szwarcensztein, Anne d'Andon, Cécile Collignon, Mathieu Robain

Therapie· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line Bevacizumab and Paclitaxel for HER2-negative Metastatic Breast Cancer: A French Retrospective Observational Study.
Veronique Dieras, Simona Pop, Frederique Berger, Marie-Eglantine Dujaric, Philippe Beuzeboc, Mathieu Robain

Anticancer Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis